{"transactions":[{"id":3056603,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":147180,"kind":"person","name":"Cavalier David","position":1,"cik":"0001289783","reported_name":"Cavalier David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-17T16:17:29.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning August 31, 2020."}],"balance_after":30000,"derivative":{"exercise_price":2.68,"expiration_date":"2030-08-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001513162-20-000171","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000171/primary_doc.xml","form_type":"4"}},{"id":3388949,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":147180,"kind":"person","name":"Cavalier David","position":1,"cik":"0001289783","reported_name":"Cavalier David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-10-24T19:41:15.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning November 30, 2019."}],"balance_after":45000,"derivative":{"exercise_price":3.87,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001513162-19-000224","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000224/primary_doc.xml","form_type":"4"}},{"id":3547098,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":147180,"kind":"person","name":"Cavalier David","position":1,"cik":"0001289783","reported_name":"Cavalier David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-29T13:02:56.000Z","date":"2019-04-29","kind":"purchase","acquired":true,"shares":2000,"price":4.21,"value":8420.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001513162-19-000115","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000115/primary_doc.xml","form_type":"4"}},{"id":3795514,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":147180,"kind":"person","name":"Cavalier David","position":1,"cik":"0001289783","reported_name":"Cavalier David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-09T19:22:18.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2010 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning October 31, 2018."}],"balance_after":45000,"derivative":{"exercise_price":5.29,"expiration_date":"2028-10-08","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001513162-18-000254","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000254/primary_doc.xml","form_type":"4"}}]}